The Effect of Oral Sprays on Salivary pH

NCT ID: NCT06148662

Last Updated: 2024-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the effect of oral foams on salivary pH changes after Coca-cola consumption in young adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a cross-over clinical trial assessing the effect of oral foams containing zink hydroxiapatite and probiotics (Lactobacillus, Bifidobacterium), Olaflur (amino fluoride), and oral spray with alkaline thermal water. The study will be conducted in six visits over a period of 1.5 months. After enrolment, dental examination will be performed using the following indices: DMFT, OHI-S index, Bleeding index. Saliva buffer capacity, salivary flow rate, and baseline salivary pH will be measured. Salivary pH changes will be registered after consumption of Coca-cola alone or followed by each of the tested products application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No intervention (negative control)

Negative control

Group Type EXPERIMENTAL

No intervention (negative control)

Intervention Type OTHER

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Water (positive control)

Tap water

Group Type EXPERIMENTAL

Water (positive control)

Intervention Type OTHER

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds. Then, participants will to rinse their mouth with tap water 60 seconds.

Dental foam "Biorepair PERIBIOMA"

Ingredients:

Aqua, Sorbitol, Xylitol, Zinc Hydroxyapatite, Aroma, Pistacia Lentiscus (Mastic) Gum Oil, Lactobacillus, Bifidobacterium, Sodium Hyaluronate, Ascorbic Acid, Hamamelis Virginiana Leaf Extract, Spirulina Platensis Extract, Calendula Officinalis Flower Extract, Tocopheryl Acetate, Retinyl Palmitate, Eucalyptus Globulus Leaf Oil, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Sodium Benzoate, Cocamidopropyl Betaine, Glycerin, Maltodextrin, Sodium Saccharin, Helianthus Annuus Seed Oil, Potassium Sorbate, BHT, Limonene, CI 16255.

Group Type EXPERIMENTAL

Dental foam "Biorepair PERIBIOMA"

Intervention Type DRUG

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental foam "Biorepair PERIBIOMA" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Dental foam "WATER:DENT"

Aqua, Xylitol, PVP, PEG-40 Hydrogenated Castor Oil, Hippophae Rhamnoides Extract, Chamomilla Recutita Extract, Sodium Benzoate, Sodium Lauryl Sulfate, Aroma, Propylene Glycol, Olaflur, Potassium Sorbate, Sodium Phosphate, Disodium Phosphate, Menthol, Bisabolol, Menthyl Lactate, PPG-26 Buteth-26, Sodium Saccharin, Sodium Methylparaben, Citric Acid, Limonene.

Group Type EXPERIMENTAL

Dental foam "WATER:DENT"

Intervention Type DRUG

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental foam "WATER:DENT" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Spray "BUCCOTHERM"

Aqua (Castéra-Verduzan Thermal Spring water), Alcohol, Xylitol, Glycerin, Camellia sinensis leaf water, Mentha piperita leaf water, Hydrogenated starch hydrolysate, Aqua, Aroma, Limonene, Benzyl alcohol, Dehydroacetic acid.

Group Type EXPERIMENTAL

Dental spray "BUCCOTHERM"

Intervention Type DRUG

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental spray "BUCCOTHERM" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention (negative control)

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Intervention Type OTHER

Water (positive control)

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds. Then, participants will to rinse their mouth with tap water 60 seconds.

Intervention Type OTHER

Dental foam "Biorepair PERIBIOMA"

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental foam "Biorepair PERIBIOMA" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Intervention Type DRUG

Dental foam "WATER:DENT"

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental foam "WATER:DENT" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Intervention Type DRUG

Dental spray "BUCCOTHERM"

The participants will be asked to hold 20 ml of "coca-cola" in their mouth for 30 seconds.

Then, participants will use a dental spray "BUCCOTHERM" to rinse their mouth. They should rinse their mouth for 60 seconds and then spit out the foam.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Females and males
* Aged between 18-44 years
* Willingness to comply with all study procedures and availability for the duration of the study.
* Subjects who signed informed consent

Exclusion Criteria

* History of chemotherapy or radiotherapy;
* An oral mucosa pathology;
* Orthodontic treatment within the previous 3 months;
* Dental bleaching within the previous 3 months;
* Withdrawal of consent;
* Patient refusal to continue participation in the study;
* Detection of an allergic reaction to any components of the dental foams or carbonated drinks used in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

I.M. Sechenov First Moscow State Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Dentistry of Sechenov University

Moscow, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

References

Explore related publications, articles, or registry entries linked to this study.

Polyakova M, Egiazaryan A, Doroshina V, Zaytsev A, Malashin A, Babina K, Novozhilova N. The Effect of Oral Care Foams and a Spray on Salivary pH Changes after Exposure to Acidic Beverages in Young Adults. Dent J (Basel). 2024 Apr 3;12(4):93. doi: 10.3390/dj12040093.

Reference Type DERIVED
PMID: 38668005 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18081215

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.